As shown in Figure 3C,D, Cos treatment markedly suppressed hyperglycaemia‐induced IκB‐α degradation and inhibited the phosphorylation of TBK1 and P65, indicating the anti‐inflammatory effect of Cos in diabetic hearts. Here, TBK1 is linked to Hyperglycemia.